Navigation Links
Robbins & Myers, Inc. Elects New Board Members
Date:10/29/2008

DAYTON, Ohio, Oct. 29 /PRNewswire-FirstCall/ -- Robbins & Myers, Inc. (NYSE: RBN) announced today that its Board of Directors has appointed Richard J. Giromini to its Board of Directors, increasing the size from seven to eight members. The Board also nominated Albert J. Neupaver to stand for election at the January 7, 2009 annual shareholder meeting, replacing Daniel W. Duval who is retiring from the board.

Richard J. Giromini, 55, is President and Chief Executive Officer of Wabash National Corporation (NYSE: WNC), a $1.1 billion manufacturer of truck trailers and related transportation equipment. Mr. Giromini joined Wabash in 2002 as Chief Operating Officer and was promoted to President and Chief Executive Officer in 2007. His career has included positions at several companies associated with the transportation industry, and he has a proven track record of successful implementation of continuous improvement initiatives to advance profitability, safety, quality, and productivity. As CEO, he has developed a long range strategic plan that provides focus on market diversification, international growth and continued operating efficiency.

Albert J. Neupaver, 57, is President and Chief Executive of Wabtec Corporation (NYSE: WAB), a $1.5 billion manufacturer of braking equipment and other parts for locomotives, freight cars and passenger rail cars. The company supplies components, systems, and repair services to its customers. Prior to Wabtec, Mr. Neupaver served as President of several large business groups of Ametek and was involved with profitable growth initiatives through product rationalization, acquisitions, and implementation of lean practices. He has been in his current position since 2006, and is now focused on growth through international expansion, adjacent product additions, and the advancement of lean concepts.

Peter C. Wallace, President and Chief Executive Office of Robbins & Myers, commented that, "Dick Giromini and Al Neupaver will be welcome additions to our Board of Directors, bringing a set of skills and management philosophy that match well with the initiatives underway at the company. During the last few years, Robbins & Myers has continued to transform to an operating company utilizing continuous improvement through the adoption of lean principles, and embracing key account management and professional selling skills programs to profitably grow in all regions."

Robbins & Myers, Inc. is a leading global supplier of highly-engineered, application-critical equipment to the global energy, industrial, chemical, and pharmaceutical markets.


'/>"/>
SOURCE Robbins & Myers, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. MedTechIQ Selects TheBrain to Visualize Expansive Biointellingence Database and Connect the Dots Between Life Sciences, Medicine and Venture Capital
2. Commonwealth Care Alliance Selects Casenet To Unify Patient Information and Improve Care for Massachusetts Members
3. Valley Baptist Health System Selects Concuitys ClearContracts to More Accurately Calculate Payments from Managed Care and Government Payers
4. MicuRx Pharmaceuticals Selects Next-Generation Antibiotic Candidate Targeting MRSA and Expands Operation in China
5. Genaera Corporation Elects Paul K. Wotton to Board of Directors
6. Battelle Selects Xie to Develop Biomarker Services
7. Array BioPharma Selects SciQuest to Automate Procurement and Enable Agile Drug Development
8. HealthEast Care System Selects Concuitys ClearContracts to Increase Contract Analysis and Negotiation Capabilities and Improve Revenue Cycle Management
9. Angiotech elects to suspend Vascular Wrap(TM) pivotal clinical trials
10. Pathology Consultants, Inc. Selects PSA, LLC, a MED3OOO Company, as Their Business Partner
11. diaDexus Selects Fisher HealthCare to Sell New Automated PLAC(R) Test
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... (PRWEB) , ... June 23, 2016 , ... ... today announced the launch of the Supplyframe Design Lab . Located in ... to explore the future of how hardware projects are designed, built and brought ...
(Date:6/23/2016)... ... ... In a new case report published today in STEM CELLS Translational Medicine, ... after being treated for breast cancer benefitted from an injection of stem cells derived ... debilitating, frequent side effect of cancer treatment. , Lymphedema refers to the ...
(Date:6/23/2016)... 23, 2016  Blueprint Bio, a company dedicated to ... medical community, has closed its Series A funding round, ... "We have received a commitment from Forentis ... need to meet our current goals," stated Matthew ... runway to complete validation on the current projects in ...
(Date:6/23/2016)... June 23, 2016 On Wednesday, June ... 4,833.32, down 0.22%; the Dow Jones Industrial Average edged 0.27% ... at 2,085.45, down 0.17%. Stock-Callers.com has initiated coverage on the ... Nektar Therapeutics (NASDAQ: NKTR ), Aralez Pharmaceuticals Inc. ... BIND ). Learn more about these stocks by ...
Breaking Biology Technology:
(Date:5/9/2016)... -- Elevay is currently known as the ... high net worth professionals seeking travel for work   ... there is still no substitute for a face-to-face meeting. ... deal with a firm handshake. This is why wealthy ... citizenship via investment programs like those offered by the ...
(Date:4/28/2016)... First quarter 2016:   , ... the first quarter of 2015 The gross margin was ... 18.8) and the operating margin was 40% (-13) Earnings ... flow from operations was SEK 249.9 M (21.2) , ... SEK 7,000-8,500 M. The operating margin for 2016 is ...
(Date:4/19/2016)... April 20, 2016 The new ... a compact web-based "all-in-one" system solution for all door ... reader or the door interface with integration authorization management ... control systems. The minimal dimensions of the access control ... the building installations offer considerable freedom of design with ...
Breaking Biology News(10 mins):